Bonesupport Holding AB (publ) (STO:BONEX)

Market Cap	12.38B
Revenue (ttm)	1.12B
Net Income (ttm)	151.92M
Shares Out	65.86M
EPS (ttm)	2.28
PE Ratio	82.49
Forward PE	41.07
Dividend	n/a
Ex-Dividend Date	n/a

Volume	175,171
Average Volume	215,391
Open	188.40
Previous Close	189.40
Day's Range	185.20 - 189.30
52-Week Range	175.60 - 405.80
Beta	0.43
RSI	46.29
Earnings Date	Feb 24, 2026

About Bonesupport Holding AB

Bonesupport Holding AB (publ), an orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; CERAMENT V, an injectable ceramic bone graft substitute t...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1999
• Employees: 139
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: BONEX

Financial Performance

In 2024, Bonesupport Holding AB's revenue was 898.73 million, an increase of 52.05% compared to the previous year's 591.08 million. Earnings were 133.75 million, a decrease of -45.41%.